ProShare Advisors LLC Raises Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR)
ProShare Advisors LLC lifted its stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 25.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 33,563 shares of the company’s stock after buying an additional 6,767 shares during the quarter. ProShare Advisors […]
